Comparison between DAS28, CDAI and HAQ-DI as tools to monitor early rheumatoid arthritis patients in eastern India

Ghosh, Anirban; Ghosh, Bikash Chandra; Pain, Shantashil; Pande, Arindam; Saha, Sandip K.; Banerjee, Arnab; Biswas, Asish

doi:10.1016/s0973-3698(11)60073-3

Cited by 17 publications

(20 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Section: Discussionsupporting

confidence: 94%

“…Moreover, we found significant correlations between DAS28 and HAQ (P = 1.8 × 10 −7 ) on the one hand and the morning stiffness duration (P = 0.045) on the other hand. These results are in accordance with those reported by Ghosh et al (44) and Khan et al (45). It is worth noting that there were significant declines in levels of both anti-CCP and RF antibodies in RA patients treated with different DMARD (disease modifying anti-rheumatic drugs) (46) or antitumor necrosis factor (anti-TNF) therapy (infliximab, (47)).…”

Section: Discussionsupporting

confidence: 94%

See 1 more Smart Citation

Anticyclic Citrullinated Peptide Antibody and Rheumatoid Factor in South Tunisian Patients With Rheumatoid Arthritis: Association With Disease Activity and Severity

Hamad

Marzouk

Kaddour

et al. 2013

Clinical Laboratory Analysis

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 94%

Section: Discussionsupporting

confidence: 94%

Anticyclic Citrullinated Peptide Antibody and Rheumatoid Factor in South Tunisian Patients With Rheumatoid Arthritis: Association With Disease Activity and Severity

Hamad

Marzouk

Kaddour

et al. 2013

Clinical Laboratory Analysis

View full text Add to dashboard Cite

show abstract

“…In our study we looked for the parameters at both Early RA and Established RA. CDAI is an established tool to assess disease activity and already validated in Indian patients suffering from RA [2].…”

Section: Discussionmentioning

confidence: 99%

“…Patients were diagnosed of having RA using ACR 2010 criteria. CDAI [2] (clinical disease activity index = swollen joint count +tender joint count +patient's global activity + evaluator's global activity) was calculated. Besides routine investigations, serum uric acid (by uricase method) and hs-CRP (by nephelometry) were also measured, at diagnosis and again after three months.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Correlation of Serum Uric Acid with Disease Activity and C-Reactive Protein in Patients Suffering from Rheumatoid Arthritis

Ghosh¹,

Baidya²,

Halder³

et al. 2016

OJRA

Self Cite

View full text Add to dashboard Cite

Rheumatoid Arthritis is characterized by increased cardiovascular morbidity and mortality that cannot be fully explained by the presence of classical cardiovascular disease (CVD) risk factors suggesting that novel risk factors may play a role. Evidence accumulated over the past decade points that uric acid (UA) may be one such novel CVD risk factor in rheumatoid arthritis, and therefore one may hypothesize that UA may contribute to the increased CVD burden in RA. The current study attempted to correlate the levels of clinical disease activity index (CDAI), high sensitivity C reactive protein (hs-CRP) and uric acid in DMARD naive non-diabetic, non-hypertensive, euthyroid patients with normal lipid profile suffering from early and established Rheumatoid Arthritis before and after 3 months of DMARD therapy. It showed a positive and significant correlation among uric acid levels and CDAI and hs-CRP levels at diagnosis. There was significant reduction in the levels of CDAI, hs-CRP and UA after 3 months of DMARD therapy with significant correlation among the changes in the 3 parameters and the change in Uric Acid also correlated with the levels of CDAI and hs-CRP at diagnosis. We propose to measure uric acid both as acute phase reactant and marker for cardiovascular morbidity in patients suffering from Rheumatoid Arthritis.

show abstract

Improving the quality of life of patients with rheumatoid arthritis after rehabilitation irrespective of the level of disease activity

et al. 2020

View full text Add to dashboard Cite

Due to the exacerbation of the disease, the rehabilitation of patients with rheumatoid arthritis is often limited. The aim of the study was to analyze the impact of a comprehensive rehabilitation on a subjective perception of pain and quality of life in patients with rheumatoid arthritis depending on the level of disease activity. The study involved 58 women with rheumatoid arthritis aged 18–60, who underwent a 4-weeks comprehensive rehabilitation program. The assessment included the disease activity level on the DAS28 scale, pain intensity on the 10-point pain scale (VAS) and the value of the CRP protein. The HAQ-DI and KALU questionnaire were used to assess the quality of life. In both groups (group A—DAS28 < 4.2, group B—DAS28 ≥ 4.2) the statistically significant effects in decreasing the level of pain and improvement of quality of life were observed. This indicates the need and effectiveness of rehabilitation regardless of the level of activity of rheumatoid arthritis according to the DAS28 scale. There were no significant changes in the CRP protein level. In conclusion, the rehabilitation of patients with moderate to high disease activity is effective and the success of comprehensive rehabilitation is demonstrated by the decrease of the DAS28 score and the pain level reported by patients, as well as improving self-assessment of health and quality of life.

show abstract

Comparison between DAS28, CDAI and HAQ-DI as tools to monitor early rheumatoid arthritis patients in eastern India

Cited by 17 publications

References 12 publications

Anticyclic Citrullinated Peptide Antibody and Rheumatoid Factor in South Tunisian Patients With Rheumatoid Arthritis: Association With Disease Activity and Severity

Anticyclic Citrullinated Peptide Antibody and Rheumatoid Factor in South Tunisian Patients With Rheumatoid Arthritis: Association With Disease Activity and Severity

Correlation of Serum Uric Acid with Disease Activity and C-Reactive Protein in Patients Suffering from Rheumatoid Arthritis

Improving the quality of life of patients with rheumatoid arthritis after rehabilitation irrespective of the level of disease activity

Contact Info

Product

Resources

About